Carlo Pozzilli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19	NEUROLOGICAL SCIENCES	2020
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2020
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register	EUROPEAN JOURNAL OF NEUROLOGY	2020
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2020
Balance worsening associated with nabiximols in multiple sclerosis	MULTIPLE SCLEROSIS	2019
Unraveling treatment response in multiple sclerosis. a clinical and mri challenge	NEUROLOGY	2019
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority	FRONTIERS IN NEUROLOGY	2019
Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis	JOURNAL OF NEUROPSYCHOLOGY	2019
Effect of dalfampridine on information processing speed impairment in multiple sclerosis	NEUROLOGY	2019
A matter of atrophy: differential impact of brain and spine volume loss on disability worsening in MS	onlinelibrary.ectrims-congress.euMULTIPLE SCLEROSIS	2019
Advances in spinal cord imaging in multiple sclerosis	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2019
The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray)	PLOS ONE	2019
Advances in preventing adverse events during monoclonal antibody management of multiple sclerosis	EXPERT REVIEW OF NEUROTHERAPEUTICS	2019
Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis	FRONTIERS IN NEUROLOGY	2019
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register	JOURNAL OF NEUROLOGY	2019
Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS	NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION	2019
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience	JOURNAL OF NEUROLOGY	2019
The Italian multiple sclerosis register	NEUROLOGICAL SCIENCES	2019
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis	NEUROEPIDEMIOLOGY	2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks	NEUROLOGY	2018